Katherine Eade - 16 Jul 2025 Form 4 Insider Report for HARVARD BIOSCIENCE INC (HBIO)

Role
Director
Signature
/s/ Katherine Eade
Issuer symbol
HBIO
Transactions as of
16 Jul 2025
Net transactions value
$0
Form type
4
Filing time
18 Jul 2025, 16:33:54 UTC
Previous filing
23 May 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Eade Katherine A. Director C/O HARVARD BIOSCIENCE, INC., 84 OCTOBER HILL ROAD, HOLLISTON /s/ Katherine Eade 18 Jul 2025 0001721318

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HBIO Common Stock Award $0 +110,000 +35% $0.000000 421,126 16 Jul 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of 110,000 restricted stock units that fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after July 16, 2025, immediately prior to the commencement of such meeting, and (ii) July 16, 2026.
F2 Includes (a) the award described in footnote (1) above and (b) 311,126 shares of common stock beneficially owned by the Reporting Person.